United States · Bill · HR
H.R. 2115 (116th)
Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act
Introduced
8 April 2019
Last action
29 October 2019 · Introduced
Status
Received in the Senate and Read twice and referred to the Committee on Finance.
Sponsors
Rep. Spanberger, Abigail Davis [D-VA-7], Rep. Arrington, Jodey C. [R-TX-19], Rep. Boyle, Brendan F. [D-PA-2], Rep. Van Drew, Jefferson [R-NJ-2], Sen. Slotkin, Elissa [D-MI], Van Taylor
Subjects
Healthcare
Source updated
28 May 2025
Summary
Public Disclosure of Drug Discounts Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to publish certain payment information regarding pharmacy benefit managers (PBMs) and prescription drugs. Specifically, the CMS must publish certain information, as reported by PBMs, relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies, in accordance with specified confidentiality requirements.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
8 April 2019
Referred
Referred to the Subcommittee on Health.
Source: Committee
8 April 2019
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
8 April 2019
Introduced
Introduced in House
Source: IntroReferral
8 April 2019
Introduced
Introduced in House
Source: IntroReferral
9 April 2019
Referred
Referred to the Subcommittee on Health.
Source: Committee
21 May 2019
Committee
Subcommittee Hearings Held.
Source: Committee
28 October 2019
Floor
Ms. Schakowsky moved to suspend the rules and pass the bill, as amended.
Source: Floor
28 October 2019
Passed
The title of the measure was amended. Agreed to without objection.
Source: Floor
28 October 2019
Passed
Motion to reconsider laid on the table Agreed to without objection.
Source: Floor
28 October 2019
Vote
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 403 - 0 (Roll no. 586). (text: CR H8516)
Source: Floor
28 October 2019
Vote
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 403 - 0 (Roll no. 586).(text: CR H8516)
Source: Floor
28 October 2019
Floor
Considered under suspension of the rules. (consideration: CR H8516-8519)
Source: Floor
28 October 2019
Vote
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Source: Floor
28 October 2019
Floor
DEBATE - The House proceeded with forty minutes of debate on H.R. 2115.
Source: Floor
29 October 2019
Introduced
Received in the Senate and Read twice and referred to the Committee on Finance.
Source: IntroReferral
Votes
28 October 2019 · passed · On Motion to Suspend the Rules and Pass, as Amended · Passed · Official source
Yes 403 · No 0 · Abstain — · Absent/not voting 28
- Rep. Ferguson, A. Drew, IV [R-GA-3]Yea
- Rep. McEachin, A. Donald [D-VA-4]Not Voting
- Rep. Hastings, Alcee L. [D-FL-20]Yea
- Rep. Finkenauer, Abby [D-IA-1]Yea
Showing the first 4 recorded positions. Vote totals above are complete.
Versions
- Referred in Senate · 29 October 2019 · Download file
- Engrossed in House · 28 October 2019 · Download file
- Introduced in House · 8 April 2019 · Download file
Documents
8 official files
Referred in Senate (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Referred in Senate (text)
Referred in Senate · EN · 29 October 2019
Referred in Senate (PDF)
Referred in Senate · EN · 29 October 2019
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Engrossed in House (text)
Engrossed in House · EN · 28 October 2019
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Engrossed in House (PDF)
Engrossed in House · EN · 28 October 2019
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Passed House
summary · EN · 28 October 2019
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 8 April 2019
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (PDF)
Introduced in House · EN · 8 April 2019
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 8 April 2019
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Spanberger, Abigail Davis [D-VA-7] · D · Sponsor
- Rep. Arrington, Jodey C. [R-TX-19] · R · Sponsor
- Rep. Boyle, Brendan F. [D-PA-2] · D · Sponsor
- Rep. Van Drew, Jefferson [R-NJ-2] · D · Cosponsor
- Sen. Slotkin, Elissa [D-MI] · D · Cosponsor
- Van Taylor · R · Cosponsor
- · ssfi00 · Standing
- · hsif00 · Standing
- · hswm00 · Standing
Related records
- related to → Lower Costs, More Cures Act of 2019
- related to ← Prescription Drug STAR Act
- related to ← More Efficient Tools to Realize Information for Consumers Act
- related to ← Shop Rx Act of 2019
- related to ← Real-Time Beneficiary Drug Cost Bill
- related to ← Lower Costs, More Cures Act of 2019
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/2115
- Open data entity: https://api.congress.gov/v3/bill/116/hr/2115
- us · 116-hr-2115 · source updated 28 May 2025